PET PHARM BIO

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

N/A

Website

www.petpharmbio.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2011

Pet Pharm Biotech manufactures and sells pharmaceutical products. It also engages in the research, development, and production of nuclear medicine drugs. Its products include FDG fluodeoxyglucose, naolixi, and sodium fluoride injections; and radioactive sodium iodide capsules. Founded in 2011, the company is based in New Taipei City, Taiwan.

Key Stats

52-Week Range

NT$46.16NT$89.85

Beta0.58

Trailing P/E105.22

Forward P/EN/A

Trailing EPS0.45

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.